$ORCL

S&P 500 fell 0.49% to 7,138.80 as investors await tech earnings and Fed decision. Polymarket predicts 61% odds of higher open April 29.

AI chip stocks tumbled on OpenAI's missed growth targets, but demand is redistributing across competing platforms rather than declining, with infrastructure fundamentals remaining strong.

Billionaire Stanley Druckenmiller exits $Sandisk 400% gain, rotates into $BE energy stock up 800% since IPO, signaling power generation as AI's new critical constraint.

Trump administration warns China on AI theft while Big Tech faces political pressure over AI development. Mixed earnings reported; Tesla sales decline sharply in California.

Sen. Murphy vows to dismantle media giants if Democrats regain power, targeting Skydance CEO Ellison amid $43B Paramount-Warner Bros. merger backlash from 1,000+ industry figures.

Geopolitical tensions support oil prices temporarily, but renewable energy transition remains structural. Three stocks offer differentiated exposure: Bloom Energy ($BE) for growth, Brookfield Renewable ($BEP) for income, NextEra Energy ($NEE) for conservative investors.

Tech hyperscalers plan $720B in 2026 AI capex. Microsoft and Alphabet positioned for high returns; Meta, Oracle, Amazon risk value-destructive maintenance spending.

$BE surges 14.3% on analyst upgrades and Oracle partnership expansion, though Q1 2026 earnings could trigger sharp reversal if guidance missed.

Clinical trial management systems market expands from $2.25B in 2025 to $4.2B by 2030, driven by cloud adoption, AI integration, and decentralized trial models.

Clinical trial data visualization market projected to grow from $0.89B (2025) to $1.82B (2030) at 15.4% CAGR, driven by AI adoption and decentralized trials.

Clinical trial software market projected to grow from $1.32B in 2025 to $2.53B by 2030, driven by AI adoption and virtual trials.

Clinical trials tech market projected to grow 59% from $51.15B (2025) to $81.46B (2030) at 9.8% CAGR, driven by AI, decentralized models, and digital transformation.

Analysts favor $APLD and $NVDA for AI exposure. Applied Digital expanding data centers; Nvidia trading at 24x forward P/E with strong earnings growth.

Oracle stock fell 6% after canceling a $1+ billion Super Micro server order, citing compliance concerns and signaling potential pullback in AI infrastructure spending.

Despite 70% revenue growth and profitability, $PLTR's lofty valuation leaves little margin for error amid scaling concerns.

Oracle expands Google Cloud partnership with AI database agent; stock rises 2.34% amid analyst calls of significant undervaluation based on $550B backlog.

Magnificent Seven tech stocks declined in Q1 2026 amid geopolitical tensions and AI investment concerns. Historical analysis suggests recovery likely, but diversification across other tech players is prudent.

Meta's $27 billion Louisiana data center investment will fund seven natural gas power plants, highlighting surging energy demand from AI workloads expected to grow 50% by 2027.

Oracle rebounds from AI concerns as multi-cloud leader, with record $553B performance obligations and AWS partnership backing 50% upside potential to $400.

Former Labor Secretary Robert Reich warns AI-driven cost-cutting inflates corporate profits and stock prices while workers face job losses and wage stagnation, widening market-economy disconnect.